Venus Remedies Ltd. share price target and research reports

Name: Latest research reports of Venus Remedies Ltd. authored by Keynotes Financial Opiniery and published by - Trendlyne research reports.
Item: Venus Remedies Ltd.
Rating: 5
Author: Keynotes Financial Opiniery

Latest analyst research reports with target prices and PDF download for VENUSREM, BSE:526953 Venus Remedies Ltd.

Search Inside the pdf :

Venus Remedies Ltd.

16 Aug 2023

464.90

2.41%

Indian Pharmaceutical company

Buy: Venus Remedies Ltd.

Keynotes Financial Opiniery

The Indian pharmaceutical and healthcare sector is anticipated to register a growth of 8-10% in FY24. Pharmaceutical businesses will continue to reassess the risk of their dependencies on global supply chains, given the resurfacing of the COVID-19 pandemic in some nations and the recent Russia-Ukraine war that has significantly impacted the operations of pharmaceutical companies globally.

Venus Remedies Ltd. is trading above its 200 day SMA of 381.3

Is Venus Remedies Ltd. worth buying?

67 Votes:

Buy 74.63%

Sell 16.42%

Hold 8.96%